SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,583.62 -115.24
(-0.25%)

Dow Jones

6,653.27 -40.35
(-0.60%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

92.29 0.37
(0.40%)

EUR-INR

106.44 -0.15
(-0.14%)

GBP-INR

123.36 -0.03
(-0.03%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Accent Microcell Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

92465

INE0Q5D01013

97.7797217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ACCENTMIC

25.07

828.82

EPS(TTM)

Face Value()

Div & Yield %

13.78

0.29

Back

j l morison (india) ltd

Aqylon Nexus reports standalone net profit of Rs 1.48 crore in the December 2025 quarter

Feb 11,2026

Net profit of Aqylon Nexus reported to Rs 1.48 crore in the quarter ended December 2025 as against net loss of Rs 22.73 crore during the previous quarter ended December 2024. Sales rose 109.75% to Rs 4.95 crore in the quarter ended December 2025 as against Rs 2.36 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4.95	2.36	110
OPM %	36.97	4.24	-
PBDT	1.49	0.15	893
PBT	1.48	0.11	1245
NP	1.48	-22.73	LP

74,563.92 -1,470.50 ( -1.93%)

46,583.62 -115.24 (-0.25%)

6,653.27 -40.35 (-0.60%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

92.29 0.37 (0.40%)

106.44 -0.15 (-0.14%)

123.36 -0.03 (-0.03%)

0.58 0.00 (0.05%)